combination of things, ER was good but not great,

combination of things, ER was good but not great, share price low allows for flippers to jump in and out, R/S looming, weak hands not willing to risk. We still have catalyst with FDA, so some school of thought is to accumulate and hold enough to still be ok even after the R/S or for a short term pop. This is a risk no doubt with the R/S looming on the 8th. But there is plenty of good ahead imo. Analyst price target is roughly 8-9 bucks. So worth the risk for me.

Here We Go!!!!